Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor a genes in the human astrocytoma cell line U373

Journal of Neurochemistry

Volumn 66, Issue 4, 1996, Pages 1496-1503

  Lieb, Klaus ^a   Kaltschmidt, Christian ^a   Kaltschmidt, Barbara ^a   Baeuerle, Patrick A ^a   Berger, Mathias ^a   Bauer, Joachim ^a   Fiebich, Bernd L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; AP 1; Interleukin 1 ; Interleukin 6; Nuclear factor B; Tumor necrosis factor

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LAVENDUSTIN A; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ASTROCYTOMA; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-6; NF-KAPPA B; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029670368     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66041496.x     Document Type: Article

References (33)

1. Aloisi F., Care A., Borsellino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G , and Peschle C. (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 149, 2358-2366.
2. Baeuerle P. A. and Baltimore D. (1988) IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
3. Baeuerle P. A. and Henkel T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
4. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Volk B., and Berger M. (1991) Interleukin-6 and alpha2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
5. Bethea J. R., Gillespie G. Y., and Benveniste E. N. (1992) Interleukin-1β induction of TNF-α gene expression: involvement of protein kinase C. J. Cell. Physiol. 152, 264-273.
6. Bomsztyk K., Rooney J. W., Iwasaki T., Rachie N. A., Dower S. K., and Sibley C. H. (1991) Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C. Cell Regul. 2, 329-335.
7. Cadman E. D., Naugles D. D., and Lee C.-M. (1994) cAMP is not involved in interleukin-1-induced interleukin-6 release from human astrocytoma cells. Neurosci. Lett. 178, 251-254.
8. Campbell I. L., Abraham C. R., Masliah E., Kemper P., Inglis J. D., Oldstone M. B., and Mucke L. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061-10065.
9. Chedid M., Yoza B. K., Brooks J. W., and Mizel S. B. (1991) Activation of AP-1 by IL-1 and phorbol esters in T cells. Role of protein kinase A and protein phosphatases. J. Immunol. 147, 867-873.
10. Chung I. Y., Kwon J., and Benveniste E. N. (1992) Role of protein kinase C activity in tumor necrosis factor-alpha gene expression. Involvement at the transcriptional level. J. Immunol. 149, 3894-3902.
11. Daffada A. A., Murray E. J., and Young S. P. (1994) Control of activator protein-1 and nuclear factor kappa B activity by interleukin-1, interleukin-6 and metals in HEPG2 cells. Biochim. Biophys. Acta 1222, 234-240.
12. de Groot R. P. and Sassone Corsi P. (1992) Activation of Jun/AP-1 by protein kinase A. Oncogene 7, 2281-2286.
13. Epstein L. G. and Gendelman H. E. (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms Ann. Neurol. 33, 429-436.
14. Geng Y., Zhang B., and Lotz M. (1993) Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol. 151, 6692-6700.
15. Hartung H. P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J. J., and Toyka K. V. (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40, 197-210.
16. Huell M., Strauss S., Volk B., Berger M., and Bauer J. (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to brains of Alzheimer's disease patients. Acta Neuropathol. (Berl.) 89, 544-551.
17. Kaltschmidt C., Kaltschmidt B., Henkel T., Stockinger H., and Baeuerle P. A. (1995) Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol. Chem. Hoppe Seyler 376, 9-16.
18. Körner M., Tarantino N., Pleskoff O., Lee L. M., and Debré P. (1994) Activation of nuclear factor κB in human neuroblastoma cell lines. J. Neurochem. 62, 1716-1726.
19. Krasnow S. W., Zhang L. Q., Leung K. Y., Osborn L., Kunkel S., and Nabel G. J. (1991) Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells. Cytokine 3, 372-379.
20. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015.
21. Muegge K., Vila M., Gusella G. L., Musso T., Herrlich P., Stein B., and Durum S. K. (1993) Interleukin 1 induction of the c-jun promoter. Proc. Natl. Acad. Sci. USA 90, 7054-7058.
22. Munoz E., Zubiaga A., Huang C.-K., and Huber B. T. (1992) Interleukin-1 induces protein tyrosine phosphorylation in T cells. Eur. J. Immunol. 22, 1391-1396.
23. Norris J. G., Tang L. P., Sparacio S. M., and Benveniste E. N. (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 152, 841-850.
24. Onoda T., Iimima H., Sasaki Y., Hamada M., Isshiki K., Naganawa H., Takeuchi T., Tatsuta K., and Umezawa K. (1989) Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. J. Nat. Prod. 52, 1252-1257.
25. Rossi B. (1993) IL-1 transduction signals. Eur. Cytokine Netw. 4, 181-187.
26. Schöbitz B., Ron de Kloet E., and Holsboer F. (1994) Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44, 397-432.
27. Schreck R., Rieber P., and Baeuerle P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
28. Schreck R., Albermann K., and Baeuerle P. A. (1992) Nuclear factor kappa B: an oxidative stress-response transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17, 221-237.
29. Sparacio S. M., Zhang Y., Vilcek J., and Benveniste E. N. (1992) Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J. Neuroimmunol. 39, 231-242.
30. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., and Volk B. (1992) Detection of interleukin-6 and alpha2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
31. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L., and Griffin D. E. (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31, 349-360.
32. Wood J. A., Wood P. L., Ryan R., Graff Radford N. R., Pilapil C., Robitaille Y., and Quirion R. (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.
33. Woodroofe M. N. and Cuzner M. L. (1993) Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 5, 583-588.